VHL and neoplasm: Our xenograft experiments revealed that P138R-pVHL and L163R-pVHL failed to suppress tumor growth, obtaining 11 tumors out of 20 sites injected with each variant (55% incidence), a similar proportion to the one obtained by parental 786-0 cell line that does not express pVHL (40% incidence).